Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.
about
Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.Ovarian cancer stem cells: still an elusive entity?Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.Non-neoplastic Fallopian Tube Epithelium Carrying Gene Mutations of a Novel SOX2 Repressor Region is Soil of High-grade Serous Ovarian Cancer.Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Expression of βV-Tubulin in Secretory Cells of the Fallopian Tube Epithelium Marks Cellular Atypia.Expression of PD-L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasion
P2860
Q30235845-C12D63C0-37FB-44AA-A084-BE28035D132DQ37713683-8904C765-7451-48B8-8991-EBD3850CE411Q38637968-2DCC83EE-0E18-4D88-9B4C-C3D81E6426C5Q42399249-646CD6A7-A109-4C68-B640-4C0A777522C0Q46342071-ED461A02-286A-499D-A580-2CA893561565Q48124146-7329D176-7B9D-44AA-AD01-1C33BE7D19C4Q49342245-AA505FB0-5BE3-4EC2-8115-FC86E5BEDE20Q58573003-E25C08D1-B84F-4A5B-95E3-1F3B5334061F
P2860
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Premalignant SOX2 overexpressi ...... covery and validation studies.
@en
Premalignant SOX2 overexpressi ...... covery and validation studies.
@nl
type
label
Premalignant SOX2 overexpressi ...... covery and validation studies.
@en
Premalignant SOX2 overexpressi ...... covery and validation studies.
@nl
prefLabel
Premalignant SOX2 overexpressi ...... covery and validation studies.
@en
Premalignant SOX2 overexpressi ...... covery and validation studies.
@nl
P2093
P2860
P50
P921
P1433
P1476
Premalignant SOX2 overexpressi ...... scovery and validation studies
@en
P2093
Ahmed Ashour Ahmed
Daniel M Hayden
Donatien Fotso Chedom
Fabrizio Miranda
Gil McVean
Ian Tomlinson
Jean-Baptiste Cazier
Karim Ahmed
Karin Hellner
P2860
P304
P356
10.1016/J.EBIOM.2016.06.048
P50
P577
2016-07-02T00:00:00Z